List of Significant Publications

  1. Juhász A, Deli G, Aschermann Z, Janszky J, Harmat M, Makkos A, Kovács M, Komoly S, Balás I, Dóczi T, Büki A, Kovács N. How Efficient Is Subthalamic Deep Brain Stimulation in Reducing Dyskinesia in Parkinson’s Disease? Eur Neurol. 2017 Apr 8;77(5-6):281-287.
  2. Toth A, Kornyei B, Kovacs N, Rostas T, Buki A, Doczi T, Bogner P, Schwarcz A. Both hemorrhagic and non-hemorrhagic traumatic MRI lesions are associated with the microstructural damage of the normal appearing white matter. Behav Brain Res. 2017 Feb 27. pii: S0166-4328(17)30324-8.
  3. Szarka N, Amrein K, Horvath P, Ivic I, Czeiter E, Buki A, Koller A, Toth P. Hypertension-Induced Enhanced Myogenic Constriction of Cerebral Arteries Is Preserved after Traumatic Brain Injury. J Neurotrauma. in press
  4. Toth P, Szarka N, Farkas E, Ezer E, Czeiter E, Amrein K, Ungvari Z, Hartings JA, Buki A, Koller A. Traumatic brain injury-induced autoregulatory dysfunction and spreading depression-related neurovascular uncoupling: Pathomechanisms, perspectives, and therapeutic implications. Am J Physiol Heart Circ Physiol. 2016 Nov 1;311(5):H1118-H1131.
  5. Nemes O, Kovacs N, Szujo S, Bodis B, Bajnok L, Buki A, Doczi T, Czeiter E, Mezosi E. Can early clinical parameters predict post-traumatic pituitary dysfunction in severe traumatic brain injury? Acta Neurochir (Wien). 2016 Dec;158(12):2347-2353.
  6. Tényi D, Gyimesi C, Horváth R, Kovács N, Ábrahám H, Darnai G, Fogarasi A, Büki A, Janszky J. Concussive convulsions: A YouTube video analysis. Epilepsia. 2016 Aug;57(8):1310-6.
  7. Cseplo P, Vamos Z, Torok O, Ivic I, Toth A, Buki A, Koller A. Hemolyzed Blood Elicits a Calcium Antagonist and High CO(2) Reversible Constriction via Elevation of Ca(2+) in Isolated Cerebral Arteries. J Neurotrauma. 2017 Jan 15;34(2):529-534.
  8. Toth A, Kovacs N, Tamas V, Kornyei B, Nagy M, Horvath A, Rostas T, Bogner P, Janszky J, Doczi T, Buki A, Schwarcz A. Microbleeds may expand acutely after traumatic brain injury. Neurosci Lett. 2016 Mar 23;617:207-12.
  9. Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, Saville B, Tyndall JA, Nash M, Buki A, Barzo P, Hack D, Tortella FC, Schmid K, Hayes RL, Vossough A, Sweriduk ST, Bazarian JJ. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury. J Neurotrauma. 2016 Jan 15;33(2):203-14.
  10. Synnot A, Gruen RL, Menon D, Steyerberg EW, Buki A, Peul WC, Elliott JH, Maas A New Approach to Evidence Synthesis in Traumatic Brain Injury: A Living Systematic Review. J Neurotrauma. in press
  11. Jeromin A, Maas AI, Buki A, Mondello S. Developing a molecular taxonomy for traumatic brain injury: a perspective to enable the development of diagnostics and therapeutics. Biomark Med. 2015;9(7):619-21.
  12. Tóth A, Schmalfuss I, Heaton SC, Gabrielli A, Hannay HJ, Papa L, Brophy GM, Wang KK, Büki A, Schwarcz A, Hayes RL, Robertson CS, Robicsek SA. Lateral Ventricle Volume Asymmetry Predicts Midline Shift in Severe Traumatic Brain Injury. J Neurotrauma. 2015 Sep 1;32(17):1307-11.
  13. Nemes O, Kovacs N, Czeiter E, Kenyeres P, Tarjanyi Z, Bajnok L, Buki A, Doczi T, Mezosi E. Predictors of post-traumatic pituitary failure during long-term follow-up. Hormones (Athens). 2015 Jul-Sep;14(3):383-91.
  14. Buki A, Kovacs N, Czeiter E, Schmid K, Berger RP, Kobeissy F, Italiano D, Hayes RL, Tortella FC, Mezosi E, Schwarcz A, Toth A, Nemes O, Mondello S. Minor and repetitive head injury. Adv Tech Stand Neurosurg. 2015;42:147-92.
  15. Mondello S, Buki A, Barzo P, Randall J, Provuncher G, Hanlon D, Wilson D, Kobeissy F, Jeromin A. CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury. Sci Rep. 2014 Oct 10;4:6446.
  16. Bukovics P, Czeiter E, Amrein K, Kovacs N, Pal J, Tamas A, Bagoly T, Helyes Z, Buki A, Reglodi D. Changes of PACAP level in cerebrospinal fluid and plasma of patients with severe traumatic brain injury. Peptides. 2014 Oct;60:18-22.
  17. Stocchetti N, Picetti E, Berardino M, Buki A, Chesnut RM, Fountas KN, Horn P, Hutchinson PJ, Iaccarino C, Kolias AG, Koskinen LO, Latronico N, Maas AI, Payen JF, Rosenthal G, Sahuquillo J, Signoretti S, Soustiel JF, Servadei F. Clinical applications of intracranial pressure monitoring in traumatic brain injury : report of the Milan consensus conference. Acta Neurochir (Wien). 2014 Aug;156(8):1615-22.
  18. Zhang Z, Zoltewicz JS, Mondello S, Newsom KJ, Yang Z, Yang B, Kobeissy F, Guingab J, Glushakova O, Robicsek S, Heaton S, Buki A, Hannay J, Gold MS, Rubenstein R, Lu XC, Dave JR, Schmid K, Tortella F, Robertson CS, Wang KK. Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PLoS One. 2014 Mar 25;9(3):e92698.
  19. Mondello S, Schmid K, Berger RP, Kobeissy F, Italiano D, Jeromin A, Hayes RL, Tortella FC, Buki A. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage. Med Res Rev. 2014 May;34(3):503-31.
  20. Mondello S, Buki A, Italiano D, Jeromin A. α-Synuclein in CSF of patients with severe traumatic brain injury. Neurology. 2013 Apr 30;80(18):1662-8.
  21. Tamas A, Reglodi D, Farkas O, Kovesdi E, Pal J, Povlishock JT, Schwarcz A, Czeiter E, Szanto Z, Doczi T, Buki A, Bukovics P. Effect of PACAP in central and peripheral nerve injuries. Int J Mol Sci. 2012;13(7):8430-48.
  22. Toth A, Kovacs N, Perlaki G, Orsi G, Aradi M, Komaromy H, Ezer E, Bukovics P, Farkas O, Janszky J, Doczi T, Buki A, Schwarcz A. Multi-modal magnetic resonance imaging in the acute and sub-acute phase of mild traumatic brain injury: can we see the difference? J Neurotrauma. 2013 Jan 1;30(1):2-10.
  23. Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, Schmid K, Tortella F, Wang KK, Hayes RL, Barzo P, Ezer E, Doczi T, Buki A. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma. 2012 Jun 10;29(9):1770-8.
  24. Mondello S, Jeromin A, Buki A, Bullock R, Czeiter E, Kovacs N, Barzo P, Schmid K, Tortella F, Wang KK, Hayes RL. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma. 2012 Apr 10;29(6):1096-104.
  25. Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, Papa L, Brophy GM, Tortella F, Hayes RL, Wang KK. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery. 2012 Mar;70(3):666-75.
  26. Mondello S, Papa L, Buki A, Bullock MR, Czeiter E, Tortella FC, Wang KK, Hayes RL. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care. 2011 Jun 24;15(3):R156.
  27. Brophy GM, Mondello S, Papa L, Robicsek SA, Gabrielli A, Tepas J 3rd, Buki A, Robertson C, Tortella FC, Hayes RL, Wang KK. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma. 2011 Jun;28(6):861-70.
  28. Kövesdi E, Bukovics P, Besson V, Nyirádi J, Lückl J, Pál J, Sümegi B, Dóczi T, Hernádi I, Büki A. A novel PARP inhibitor L-2286 in a rat model of impact acceleration head injury: an immunohistochemical and behavioral study. Int J Mol Sci. 2010 Mar 26;11(4):1253-68.
  29. Mondello S, Robicsek SA, Gabrielli A, Brophy GM, Papa L, Tepas J, Robertson C, Buki A, Scharf D, Jixiang M, Akinyi L, Muller U, Wang KK, Hayes RL. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J Neurotrauma. 2010 Jul;27(7):1203-13.
  30. Büki A, Kövesdi E, Pál J, Czeiter E. Clinical and model research of neurotrauma. Methods Mol Biol. 2009;566:41-55.
  31. Czeiter E, Büki A, Bukovics P, Farkas O, Pál J, Kövesdi E, Dóczi T, Sándor J. Calpain inhibition reduces axolemmal leakage in traumatic axonal injury. Molecules. 2009 Dec 9;14(12):5115-23.
  32. Kövesdi E, Lückl J, Bukovics P, Farkas O, Pál J, Czeiter E, Szellár D, Dóczi T, Komoly S, Büki A. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien). 2010 Jan;152(1):1-17.
  33. Kövesdi E, Tamás A, Reglodi D, Farkas O, Pál J, Tóth G, Bukovics P, Dóczi T, Büki A. Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats. Neurotox Res. 2008 Apr;13(2):71-8.
  34. Czeiter E, Pal J, Kovesdi E, Bukovics P, Luckl J, Doczi T, Buki A. Traumatic axonal injury in the spinal cord evoked by traumatic brain injury. J Neurotrauma. 2008 Mar;25(3):205-13.
  35. Kovesdi E, Czeiter E, Tamas A, Reglodi D, Szellar D, Pal J, Bukovics P, Doczi T, Buki A. Rescuing neurons and glia: is inhibition of apoptosis useful? Prog Brain Res. 2007;161:81-95.
  36. Martens-Lobenhoffer J, Sulyok E, Czeiter E, Büki A, Kohl J, Firsching R, Tröger U, Bode-Böger SM. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. J Neurosci Methods. 2007 Aug 15;164(1):155-60.
  37. Czigner A, Mihály A, Farkas O, Büki A, Krisztin-Péva B, Dobó E, Barzó P. Kinetics of the cellular immune response following closed head injury. Acta Neurochir (Wien). 2007 Mar;149(3):281-9.
  38. Tamás A, Zsombok A, Farkas O, Reglödi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats. J Neurotrauma. 2006 May;23(5):686-95.
  39. Büki A, Povlishock JT. All roads lead to disconnection?–Traumatic axonal injury revisited. Acta Neurochir (Wien). 2006 Feb;148(2):181-93.
  40. Farkas O, Polgár B, Szekeres-Barthó J, Dóczi T, Povlishock JT, Büki A. Spectrin breakdown products in the cerebrospinal fluid in severe head injury–preliminary observations. Acta Neurochir (Wien). 2005 Aug;147(8):855-61.
  41. Farkas O, Tamás A, Zsombok A, Reglodi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury. Regul Pept. 2004 Dec 15;123(1-3):69-75.
  42. Czigner A, Mihály A, Farkas O, Büki A, Krisztin-Péva B, Dobó E, Barzó P. Dynamics and regional distribution of c-fos protein expression in rat brain after a closed head injury. Int J Mol Med. 2004 Aug;14(2):247-52.
  43. Buki A, Farkas O, Doczi T, Povlishock JT. Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma. 2003 Mar;20(3):261-8.
  44. Büki A, Okonkwo DO, Wang KK, Povlishock JT. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci. 2000 Apr 15;20(8):2825-34.
  45. Büki A, Walker SA, Stone JR, Povlishock JT. Novel application of tyramide signal amplification (TSA): ultrastructural visualization of double-labeled immunofluorescent axonal profiles. J Histochem Cytochem. 2000 Jan;48(1):153-61.
  46. Büki A, Horváth Z, Kalló I, Liposits Z, Lengvári I, Dóczi TP. Peptidergic innervation of human cerebral blood vessels and saccular aneurysms. Acta Neuropathol. 1999 Oct;98(4):383-8.
  47. Povlishock JT, Buki A, Koiziumi H, Stone J, Okonkwo DO. Initiating mechanisms involved in the pathobiology of traumatically induced axonal injury and interventions targeted at blunting their progression. Acta Neurochir Suppl. 1999;73:15-20.
  48. Büki A, Koizumi H, Povlishock JT. Moderate posttraumatic hypothermia decreases early calpain-mediated proteolysis and concomitant cytoskeletal compromise in traumatic axonal injury. Exp Neurol. 1999 Sep;159(1):319-28.
  49. Büki A, Okonkwo DO, Povlishock JT. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J Neurotrauma. 1999 Jun;16(6):511-21.
  50. Büki A, Dóczi T, Vetö F, Horváth Z, Gallyas F. Initial clinical experience with a combined pulsed holmium-neodymium-YAG laser in minimally invasive neurosurgery. Minim Invasive Neurosurg. 1999 Mar;42(1):35-40.
  51. Büki A, Siman R, Trojanowski JQ, Povlishock JT. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol. 1999 Apr;58(4):365-75.
  52. Vajda Z, Büki A, Vetö F, Horváth Z, Sándor J, Dóczi T. Transcranial Doppler-determined pulsatility index in the evaluation of endoscopic third ventriculostomy (preliminary data). Acta Neurochir (Wien). 1999;141(3):247-50.
  53. Okonkwo DO, Büki A, Siman R, Povlishock JT. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport. 1999 Feb 5;10(2):353-8.
  54. Büki A, Horváth Z, Kövér F, Vet F, Dóczi T. Occlusive hydrocephalus complicating tuberous sclerosis: report of two cases. Eur J Neurol. 1996 May;3(3):255-9.